Literature DB >> 10562810

Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.

F Imbert-Bismut1, F Charlotte, B Turlin, L Khalil, A Piton, P Brissot, Y Le Charpentier, J Delattre, P Opolon, Y Deugnier, T Poynard.   

Abstract

AIMS: To validate a method of assessment of low hepatic iron concentration based on a biochemical colorimetric assay plus histological scoring.
METHODS: The within-day and day to day precision of the iron colorimetric assay was determined on frozen rat liver. The coefficient of variation (CV) of iron measurement in two separate samples from the same liver was determined for 21 deparaffinised human biopsies. The intra- and interlaboratory variability of the colorimetric assay and histological scoring were assessed on 38 deparaffinised liver biopsies.
RESULTS: For the within-day test, the CV was 11% (5.1 (0.6) mumol/g dry weight (dw), mean (SD) iron concentration). For the day to day test, the CV was 19.5% (8.2 (1.6) mumol/g dw). The CV was 14.7% for iron concentration determined in two separate samples from the same liver. By correlation and kappa concordance tests, the intra- and interlaboratory variability of the hepatic iron colorimetric assay and iron histological scoring was slight. Absence of stainable iron corresponded to a liver iron concentration < or = 20 mumol/g dw.
CONCLUSIONS: A combination of two complementary methods, colorimetric measurement and histological scoring, is an accurate and reliable way of determining low iron concentrations in deparaffinised human liver biopsies. In secondary haemosiderosis, such methods would be essential for investigating the role of low iron overload in fibrogenesis and during the response to antiviral treatment in chronic viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562810      PMCID: PMC501429          DOI: 10.1136/jcp.52.6.430

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Liver iron concentration, stainable iron, and total body storage iron.

Authors:  M Barry
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

2.  Variability in hepatic iron concentration measurement from needle-biopsy specimens.

Authors:  J P Villeneuve; M Bilodeau; R Lepage; J Côté; M Lefebvre
Journal:  J Hepatol       Date:  1996-08       Impact factor: 25.083

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Measurement of iron in liver biopsies--a comparison of three analytical methods.

Authors:  H G Kreeftenberg; B J Koopman; J R Huizenga; T van Vilsteren; B G Wolthers; C H Gips
Journal:  Clin Chim Acta       Date:  1984-12-29       Impact factor: 3.786

5.  Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

Authors:  P Brissot; M Bourel; D Herry; J P Verger; M Messner; C Beaumont; F Regnouard; B Ferrand; M Simon
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

6.  Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection.

Authors:  N Arber; M Moshkowitz; F Konikoff; Z Halpern; A Hallak; M Santo; E Tiomny; M Baratz; T Gilat
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

7.  Response to interferon alpha therapy is influenced by the iron content of the liver.

Authors:  D H Van Thiel; L Friedlander; S Fagiuoli; H I Wright; W Irish; J S Gavaler
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

Review 8.  Role of free radicals in liver diseases and hepatic fibrosis.

Authors:  R S Britton; B R Bacon
Journal:  Hepatogastroenterology       Date:  1994-08

9.  Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications.

Authors:  J K Olynyk; R O'Neill; R S Britton; B R Bacon
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

10.  Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report.

Authors:  F Farinati; R Cardin; N de Maria; P E Lecis; G Della Libera; P Burra; C Marafin; G C Sturniolo; R Naccarato
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

View more
  5 in total

Review 1.  Pathology of Hepatic Iron Overload.

Authors:  Marcela A Salomao
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 2.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

3.  Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.

Authors:  John Porter; Renzo Galanello; Giuseppe Saglio; Ellis J Neufeld; Elliott Vichinsky; Maria Domenica Cappellini; Nancy Olivieri; Antonio Piga; Melody J Cunningham; Denis Soulières; Norbert Gattermann; Gilbert Tchernia; Johan Maertens; Patricia Giardina; Janet Kwiatkowski; Giovanni Quarta; Michael Jeng; Gian Luca Forni; Michael Stadler; Holger Cario; Louisette Debusscher; Matteo Della Porta; Mario Cazzola; Peter Greenberg; Giuliana Alimena; Bertrand Rabault; Insa Gathmann; John Malcolm Ford; Daniele Alberti; Christian Rose
Journal:  Eur J Haematol       Date:  2007-11-17       Impact factor: 2.997

4.  Hepatic iron overload is associated with hepatocyte apoptosis during Clonorchis sinensis infection.

Authors:  Su Han; Qiaoran Tang; Rui Chen; Yihong Li; Jing Shu; Xiaoli Zhang
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

5.  Histological Scores Validate the Accuracy of Hepatic Iron Load Measured by Signal Intensity Ratio and R2* Relaxometry MRI in Dialysis Patients.

Authors:  Guy Rostoker; Mireille Laroudie; Raphaël Blanc; Mireille Griuncelli; Christelle Loridon; Fanny Lepeytre; Clémentine Rabaté; Yves Cohen
Journal:  J Clin Med       Date:  2019-12-19       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.